30.3.2021
•
News
Webinar in cooperation with Legal 500
KŠB, in cooperation with the prestigious rating agency Legal 500, organized a webinar on the topic of Post Covid M&A - A new normal for navigating the transactional landscape in the Czech Republic?
The future of M&A transactions was discussed at the webinar by KŠB partners Dagmar Dubecká, Martin Šolc, Drahomír Tomašuk and Jan Lasák and together with them the managing partner of the consulting company CORPIN Jiří Hák. The aim of the webinar was to introduce participants to the basic information they need for orientation in the investment environment in the Czech Republic, and to outline trends that will affect transactions in the covid and post-covid period. A link to the webinar can be found here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
